dacarbazine and apyrase

dacarbazine has been researched along with apyrase in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fietkau, R; Frey, B; Gaipl, US; Werthmöller, N; Wunderlich, R	1

Other Studies

1 other study(ies) available for dacarbazine and apyrase

Article	Year
Modulation of radiochemoimmunotherapy-induced B16 melanoma cell death by the pan-caspase inhibitor zVAD-fmk induces anti-tumor immunity in a HMGB1-, nucleotide- and T-cell-dependent manner. Cell death & disease, 2015, May-14, Volume: 6 Topics: Amino Acid Chloromethyl Ketones; Animals; Apoptosis; Apyrase; B7-2 Antigen; Caspase Inhibitors; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Chemoradiotherapy; Combined Modality Therapy; Dacarbazine; Dendritic Cells; Histocompatibility Antigens Class II; HMGB1 Protein; Homeodomain Proteins; Hyperthermia, Induced; Interferon-gamma; Lymphocyte Activation; Macrophages, Peritoneal; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Mice, Knockout; Myeloid Differentiation Factor 88; Radiation, Ionizing; Tumor Necrosis Factor-alpha	2015

Article

Year

Modulation of radiochemoimmunotherapy-induced B16 melanoma cell death by the pan-caspase inhibitor zVAD-fmk induces anti-tumor immunity in a HMGB1-, nucleotide- and T-cell-dependent manner.

Cell death & disease, 2015, May-14, Volume: 6

Topics: Amino Acid Chloromethyl Ketones; Animals; Apoptosis; Apyrase; B7-2 Antigen; Caspase Inhibitors; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Chemoradiotherapy; Combined Modality Therapy; Dacarbazine; Dendritic Cells; Histocompatibility Antigens Class II; HMGB1 Protein; Homeodomain Proteins; Hyperthermia, Induced; Interferon-gamma; Lymphocyte Activation; Macrophages, Peritoneal; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Mice, Knockout; Myeloid Differentiation Factor 88; Radiation, Ionizing; Tumor Necrosis Factor-alpha

2015